ArticleTrials2021

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.

Iwein Gyselinck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.